SCHEMBL10041277

SCHEMBL10041277

CC(C)(C)c1nc2ccccc2n1-c1cccc(-n2c(C(C)(C)C)nc3ccccc32)c1C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
TSHR P16473 3/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
CNR2 P34972 2/20 0.41
PIK3CB P42338 1/20 0.41
SLC22A12 Q96S37 1/20 0.40
CYP2C9 P11712 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
APEX1 P27695 1/20 0.36
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25878270 0.81 CNR2 (0.54) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL14124469 0.80 TSHR (0.45) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL14124486 0.80 TSHR (0.45) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL10041271 0.79 TSHR (0.42) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL10041281 0.79 MAPK1 (0.48) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL10041284 0.78 MAPK1 (0.53) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL10041278 0.78 TSHR (0.41) MAPK1TSHRALDH1A1KDM4ECNR2
SCHEMBL10041261 0.76 CNR2 (0.46) MAPK1TSHRALDH1A1KDM4EHPGD
SCHEMBL22600025 0.76 TSHR (0.39) MAPK1TSHRCNR2SLC22A12HTT
SCHEMBL10041276 0.75 GSR (0.52) MAPK1TSHRALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8147987-B2 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2012-04-03 US disclosed
US-8147987-B2 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2012-04-03 US disclosed
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2007-08-30 US disclosed
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element RPL31, RPL38, RPL39 MAPK1 1465/4885TSHR 1844/4885ALDH1A1 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.